Introduction
The INK4a/ARF locus encodes two different proteins: a cyclindependent kinase inhibitor named p16
INK4a , 1 and the structurally unrelated p19 ARF . 2 
Inactivation of the p16
INK4a gene is a frequent event in NHLs. 3, 4 Genomic alterations of the coding p19 ARF sequences have been also described in T cell acute lymphoblastic leukemia. 5 Additionally, human p19 ARF protein has not been detected in hematopoietic cell lines that abundantly express the alternative beta transcript of the gene. 6 Three mechanisms for the inactivation of p16
INK4a gene have been reported, including deletion, point mutation, and 5ЈCpG methylation at its promoter region. 7, 8 In previous papers, we analyzed the mutational status of TP53 and p16
INK4a genes, and the DNA-methylation levels at the promoter region of p16
INK4a in a set of NHLs. Furthermore, an allelotypic analysis using flanking external markers allowed us to demonstrate frequent allelic losses around the INK4a/ARF locus. [8] [9] [10] The goal of this work is to evaluate the occurrence of deletions and genetic instability at the INK4a/ARF locus using two new internal polymorphic microsatellites, one located at the intron 1 of the p16
INK4a gene, and the other one placed 3Ј dowstream to the exon 1␤ of p19 ARF , in order to clarify the role of this locus in the progression of NHLs. 
Figure 1
Allelotype analysis of B cell NHLs using two new microsatellite markers at the INK4a/ARF locus. LOH, loss of heterozygosity; i, instability; T, tumour; N, normal sample.
Materials and methods

Tumor samples
This study was performed in 30 paired normal and tumor samples from patients with NHLs of B cell lineage, which had been previously characterized by us.
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Microsatellite markers
Microsatellites used in this work were identified by a search of data banks (Burubian DM, Mitchell N, Roe BA, unpublished 1997; Sveen L, Olopade FI, Rowley JD, unpublished 1997; accession numbers: AC000048 and AC000049). The cosmid clone c66 (AC000048) includes the coding sequence of the p16
INK4a gene, whereas the cosmid clone c86 (AC000049) contains the coding sequence of the p15
INK4b
gene and the exon 1␤ from p19
ARF
. On the basis of this information we designed primers recognizing DNA sequences that flank a mononucleotide tract of (A) 23 at intron 1 of p16
INK4a
gene for PCR amplification (hMp16␣-I1.F, hMp16a-I1.R). Table 1 Results of the allelotype analysis of the INK4a/ARF locus in 30 NHLs using the two internal markers (p19 and p16) and four flanking markers (D9S171, D9S942, D9S958 and IFNA)
Data with flanking markers derived from a previous paper. 9 NI, non-informative, both normal and tumor are homozygous and there is no evidence of genetic alterations. LOH, loss of heterozygosity, partial or total elimination of one of the two alleles in the tumour sample; i, microsatellite instability: tumour sample exhibits allelic variant of different size with respect to that the normal sample; L and H, low-and high-grade, respectively; NS, non-studied; N, normal: normal and tumor sample are heterozygous and there is no evidence of any difference between the samples; ALC, anaplasic large cell; BL, Burkitt's; CB, centroblastic; CC, centrocytic; MALT, mucous associated lymphoid tissue; B N-H, non-Hodgkin lymphoma of the B cell lineage.
Likewise, primers to amplify a DNA fragment including a (CA) 14 repeat which is located 268 bp downstream exon 1␤ was also designed (hMp19ARF-I1.F,hMp19ARF-I1.R). Oligonucleotide primers were made using the Primer3 program by Steve Rozen, Helen J Skaletsky, (1996, 1997) (available at http://wwwgenome.wi.mit.edu/genome software/other/primer3.html). The oligonucleotide sequences used in this survey were as follows: hMp16␣-I1.F, 5Ј,CAATTACCACATTCTGCGCTT 3Ј; hMp16␣-I1.R, 5ЈCAGGCAGAGAGCACTGTGAG 3Ј; hMp19ARF-I1.F, 5ЈGGAAACTGAGGCGAACAGAG 3Ј; hMp19ARF-I1.R, 5Ј TATCTCACGGGTCCTCCACT 3Ј. . Two hundred nanograms of genomic DNA as template were used in each PCR reactions. PCR amplifications were carried out in a Perkin-Elmer Cetus 2400 thermocycler (Madrid, Spain), with cycling times of 94°C for 10 min (one cycle), and by a variable number of cycles (from 25 to 34) of 30 s at 94°C, 30 s at 55-57°C, and 1 min at 72°C. The two final steps were incubation at 72°C for 5 min and cooling to 10°C. Amplified DNAs were electrophoresed on 12% nondenaturing acrylamide-Tris-HCl, pH 8.8 buffered gels. After electrophoresis the DNA fragments were detected using the Bio-Rad silver stain kit (Madrid, Spain).
PCR amplification and allelotypic analysis
Allelic losses for the two analyzed microsatellites were scored as we described previously in Fernández-Piqueras et al. 9 Comparative multiplex PCR, using as control the D14S51 microsatellite, was performed to avoid amplification of DNA from contaminating normal cells. An optimal cycle number, defined as that producing detectable bands of minimal intensity with the normal sample, was also established for each type of PCR amplification. Amplifications were repeated a minimum of three times to rule out PCR artefacts.
We considered that microsatellite instability occurred when mobility shifts resulting in alleles other than those present in the normal samples were observed in tumors.
Results and discussion
In an attempt to evaluate the occurrence of deletions and genetic instability at the INK4a/ARF locus, we screened 30 paired samples from patients with NHLs using two new internal microsatellite markers (hMp16␣-I1 and hMp19ARF-I1) ( Figure  1 ). The observed patterns for loss of heterozygosity and microsatellite instability are showed in Table 1 . This Table  also contains previous data from an allelotypic analysis we carried out using four flanking microsatellites. 9 Comparative analysis indicates that LOH detected at hMp19ARF-I1 in tumor M3770 (high grade, Burkitt's) is consistent with the generalized pattern of LOH that we had found at the four 9p21 flanking markers, and showed the involvement of the INK4a/ARF locus in the development of this tumor. On the contrary, this locus is not affected in tumors L-421 (high-grade, anaplasic large cell), L-272 (high-grade, Burkitt's) and L-159 (high-grade, centroblastic) which exhibited LOH at some of the flanking markers.
With regard to microsatellite instability, the use of the internal markers allowed us to demonstrate two new cases of instability in tumors L-446 (centrocytic) and L-442 (mucous associated lymphoid tissue). Interestingly, both cases are lowgrade NHLs, indicating that this phenomenon could be an early event occurring during the development of these tumors.
All allelotypic analyses of the INK4a/ARF locus have been performed with flanking microsatellite markers, or by using internal polymorphisms with a low informativeness. 11 In this study, we used two polymorphic internal microsatellites that presumably, exhibit a higher informativeness. Furthermore, the discrepancies that we have observed between data obtained with flanking and internal markers, clearly indicated the need for these internal markers to confirm the involvement of the INK4a/ARF locus in the development of NHLs.
